Table 1 Baseline patient characteristics
|  | HMB/Arg/Gln n = 19 N (%) | No HMB/Arg/Gln n = 19 N (%) | All n = 38 N (%) | |
|---|---|---|---|---|
Age | 60 or below | 6 (32) | 6 (32) | 12 (32) |
Over 60 | 13 (68) | 13 (68) | 26 (68) | |
Sex | Male | 12 (63) | 11 (58) | 23 (61) |
Female | 7 (37) | 8 (42) | 15 (39) | |
Diagnosis | SCLC | 3 (16) | 3 (16) | 6 (16) |
NSCLC | 16 (84) | 16 (84) | 32 (84) | |
Staginga | Locally advanced | 8 (42) | 6 (32) | 14 (37) |
Metastatic | 11 (58) | 13 (68) | 24 (63) | |
WHO Performance status | 0 | 2 (10.5) | 7 (37) | 9 (24) |
1 | 15 (79) | 11 (58) | 26 (68) | |
2 | 2 (10.5) | 1 (5) | 3 (8) | |